GRCE vs SO · $35.0M cap vs P/E 22, rev $29.55B
Grace Therapeutics, Inc. (GRCE) versus Southern Company (SO) — a side-by-side from cached financials, not a winner call.
Grace Therapeutics, Inc. (GRCE) is a biotechnology company listed on US.
Southern Company (SO) is a utilities - regulated electric company listed on US.
GRCE does not have a complete income-statement cache yet.
Latest reported SO revenue for 2025-12-31 was $29.55B. Net income was $4.34B. Revenue was up 10.6% from 2024-12-31 to 2025-12-31. SO currently screens at market cap $101.55B and trailing P/E 22.1.
GRCE currently screens at market cap $35.0M. SO currently screens at market cap $101.55B and trailing P/E 22.1.
Not investment advice. Open the GRCE and SO stock pages for the full models.
Not investment advice.